HELE Intrinsic Value Calculator – Uncovering the Value Behind Helen of Troy: Why She’s Conservatively Priced

December 16, 2023

☀️Trending News

Helen ($NASDAQ:HELE) of Troy is a carefully priced company with a distinct purpose. As the company’s stock has grown over the years, the value behind Helen of Troy has become increasingly apparent for investors. At first glance, Helen of Troy’s stock may appear to be priced conservatively, but upon closer inspection, it’s clear that the company has strategically priced their stock to optimize their growth potential. By pricing shares in line with the industry standards, they’re able to attract more investors who have the potential to drive their success even further. As the stock continues to appreciate, it’s likely that prices will eventually reach higher levels. In addition to its carefully calculated stock prices, Helen of Troy also offers investors diversified options with their lineup of consumer products.

From healthcare products to beauty products and home and lifestyle products, Helen of Troy has something for everyone. As a result, investors have the opportunity to benefit from the company’s wide range of offerings, and enjoy a steady stream of income. When considering an investment in Helen of Troy, it’s important to keep in mind that the company is reliably priced with a purpose. By analyzing the company’s current stock prices, investors can discern the true value behind the stock and make an informed decision about whether or not to invest in the future growth of Helen of Troy.

Price History

Helen of Troy is a company that has seen significant growth in their stock prices recently, with the stock opening at $118.5 on Thursday and closing at $123.9 – a 6.8% increase from the previous closing price of 116.0. This increase in stock price suggests that Helen of Troy is currently trading at a conservative price, which makes it an attractive choice for investors. Despite the positive movement of its stock prices, Helen of Troy is still priced conservatively. It has reported strong financials, indicating that the company is performing well and is in a position of strength. This has led analysts to declare that the company is currently undervalued, and that this presents an excellent opportunity for investors to purchase shares at a discounted rate. Furthermore, Helen of Troy’s management has undertaken a range of initiatives that have contributed to the company’s ongoing success and profitability.

The company has invested in research and development to develop innovative products, as well as introducing cost-saving measures to improve efficiency and reduce operating costs. These efforts have enabled the company to remain competitive in the marketplace and have translated into increased shareholder value. In conclusion, Helen of Troy’s stock is currently trading at a conservative price, and this presents investors with an opportunity to purchase shares at an attractive rate. The company has demonstrated strong financials and implemented a range of initiatives to ensure ongoing success, resulting in increased shareholder value. As such, investors should take notice of Helen of Troy as an appealing option for long-term investment. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for HELE. More…

    Total Revenues Net Income Net Margin
    2.01k 137.97 8.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for HELE. More…

    Operations Investing Financing
    367.73 -319.33 106.78
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for HELE. More…

    Total Assets Total Liabilities Book Value Per Share
    2.9k 1.4k 63.87
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for HELE are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    2.4% -3.0% 10.9%
    FCF Margin ROE ROA
    12.8% 9.0% 4.7%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – HELE Intrinsic Value Calculator

    GoodWhale has conducted an analysis of the financials of HELEN OF TROY, and our proprietary Valuation Line has calculated a fair value for each share of HELEN OF TROY to be around $185.5. However, currently the stock is trading at a much lower price of $123.9, indicating that it is undervalued by 33.2%. This presents a great opportunity for investors looking to invest in HELEN OF TROY as they can purchase the stock at a discounted rate. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The Company is a leading designer, developer and marketer of consumer products sold under internationally recognized brand names such as OXO, Good Grips, OXO Steel, Hydrotherm, and Splendide. The Company’s products are distributed through a variety of channels, including mass merchandisers, home centers, grocery stores, drug stores, department stores, and e-commerce sites. The Company operates in two segments: Housewares and International Housewares. The Company’s competitors include Lykis Ltd, Taiyen Biotech Co Ltd, Aekyung Industrial Co Ltd, among others.

    – Lykis Ltd ($BSE:530689)

    Lykis Ltd is a publicly traded company with a market capitalization of 763.38 million as of 2022. The company has a return on equity of 18.71%. Lykis Ltd is engaged in the business of providing engineering and construction services. The company has a strong presence in the Asia-Pacific region.

    – Taiyen Biotech Co Ltd ($TWSE:1737)

    Taiyen Biotech Co Ltd is a pharmaceutical company that develops, manufactures, and markets prescription drugs and over-the-counter medicines. The company has a market cap of 6.01B as of 2022 and a Return on Equity of 4.56%. Taiyen Biotech Co Ltd was founded in Taiwan in 1984 and has since expanded its operations to China, Hong Kong, and Macau. The company’s products include antibiotics, anti-fungals, antivirals, and anti-inflammatories.

    – Aekyung Industrial Co Ltd ($KOSE:018250)

    Aekyung Industrial Co Ltd is a large conglomerate based in South Korea with a market cap of 283.07B as of 2022. The company has a Return on Equity of 3.54%. Aekyung Industrial Co Ltd is involved in a wide range of businesses including chemicals, petrochemicals, oil refining, construction, and retail.

    Summary

    Helen of Troy Limited (HELE) is a publicly traded consumer goods company that has experienced a rise in stock price on the same day. The company offers products such as personal care, home and residential products, and healthcare products. They have a conservative pricing strategy and have had strong stock performance due to their focus on value and cost-effective solutions to their customers. It is considered to be a safe bet for investors who are looking for stability and long-term returns.

    Analysts are predicting strong growth opportunities due to their diverse portfolio of products and their ability to capitalize on industry trends. Despite some risks with their lower-priced product lines, the company is estimated to continue its growth and provide additional value to its shareholders in the future.

    Recent Posts

    Leave a Comment